The beneficial effects of ER agonists, particularly estrogens, on brain tissue undergoing hypoxia and/or ischemia have been extensively reported; however, only a few research reports have focused on membrane ERs, mainly GPER1 (previously GPR30). This evidence concerns the gene ESR1 and ischemia.